Crucell

Crucell company information, Employees & Contact Information

Explore related pages

Related company profiles:

Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. We do this by discovering, developing, manufacturing and marketing products that combat major threats to the health of people worldwide. Our specialty is fighting infectious diseases—a growing healthcare challenge. Innovation is the drive force behind our strong research & development (R&D) pipeline, with promising products in pre-clinical and clinical development. Crucell product candidates include flu-mAb, and antibody product effective against a broad range of influenza virus strains, tuberculosis and malaria vaccines, as well as a rabies monoclonal antibody combination-all produced on our unique PER.C6® human-cell technology. Currently we are combating twelve major infectious diseases with our range of marketed vaccines in the paediatric, travel & endemic and respiratory fields. We are the largest independent vaccine company in the world. The combination of our innovative technologies and creative minds drives Crucell’s success, which we measure in human and business terms. Headquartered in Leiden, the Netherlands, Crucell currently employs over 1300 people and has offices in China, Indonesia, Italy, Korea, Malaysia, Spain, Sweden, Switzerland, the UK the USA and Vietnam. Crucell N.V. is listed on NYSE Euronext and NASDAQ (CRXL) and the SIX Swiss Exchange (CRX).

Company Details

Employees
101
Phone
31 71 519 9100
Email
in****@****ell.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Looking for a particular Crucell employee's phone or email?

Crucell Questions

News

COVER STORY: EUROPEAN BIOTECHNOLOGY - Site Selection Magazine

COVER STORY: EUROPEAN BIOTECHNOLOGY Site Selection Magazine

Will J&J turbocharge Crucell's vaccine portfolio? - Nature

Will J&J turbocharge Crucell's vaccine portfolio? Nature

A common solution to group 2 influenza virus neutralization - PNAS

A common solution to group 2 influenza virus neutralization PNAS

DSM and Crucell Turn Per.C6 R&D JV into Fully Fledged Biopharmaceutical Company - Genetic Engineering and Biotechnology News

DSM and Crucell Turn Per.C6 R&D JV into Fully Fledged Biopharmaceutical Company Genetic Engineering and Biotechnology News

Calmune Collaborates With Crucell On Research Development, Production And Marketing Of Vaccines - Quick Facts - RTTNews

Calmune Collaborates With Crucell On Research Development, Production And Marketing Of Vaccines - Quick Facts RTTNews

Development of a High-Capacity MAb Capture Step Based on Cation-Exchange Chromatography - BioProcess International

Development of a High-Capacity MAb Capture Step Based on Cation-Exchange Chromatography BioProcess International

Lonza, Crucell Ink Permexcis Pact - Contract Pharma

Lonza, Crucell Ink Permexcis Pact Contract Pharma

SEC Filing: Crucell - Offer document for Johnson & Johnson's acquisition of Crucell - MLex

SEC Filing: Crucell - Offer document for Johnson & Johnson's acquisition of Crucell MLex

Daniel Carleton Gajdusek (1923–2008) - Nature

Daniel Carleton Gajdusek (1923–2008) Nature

Crucell reveals registration of Hepavax-Gene in China - Quick Facts - RTTNews

Crucell reveals registration of Hepavax-Gene in China - Quick Facts RTTNews

GSK and Crucell Team Up to Develop a Prime-Boost Malaria Vaccine - Genetic Engineering and Biotechnology News

GSK and Crucell Team Up to Develop a Prime-Boost Malaria Vaccine Genetic Engineering and Biotechnology News

A Review of Therapeutic Protein Expression By Mammalian Cells - BioProcess International

A Review of Therapeutic Protein Expression By Mammalian Cells BioProcess International

Crucell strikes exclusive license deal with Talecris - Update - RTTNews

Crucell strikes exclusive license deal with Talecris - Update RTTNews

Crucell INKS Second Exclusive License deal with Talecris Biotherapeutics - Quick facts - RTTNews

Crucell INKS Second Exclusive License deal with Talecris Biotherapeutics - Quick facts RTTNews

Crucell Q2 Loss narrows - Quick Facts - RTTNews

Crucell Q2 Loss narrows - Quick Facts RTTNews

MedImmune, Crucell Collaborate To Develop New Antibodies For Treatment, Prevention Of Hospital-acquired Bacterial Infection - Quick Facts - RTTNews

MedImmune, Crucell Collaborate To Develop New Antibodies For Treatment, Prevention Of Hospital-acquired Bacterial Infection - Quick Facts RTTNews

Top Crucell Employees

  • Geco Floor

    Geco Floor

    n/a

    Zoetermeer, South Holland, Netherlands, Netherlands
    1
    yahoo.com
  • Maik Slijpen

    Maik Slijpen

    n/a

    Seoul Incheon Metropolitan Area, Korea, Republic Of
    4
    its.jnj.com, janssen.com, bernabiotech.co.kr, crucell.kr

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant